Michael Wiliams

Michael Wiliams

Michael Wiliams

Endologix is a developer and manufacturer of minimally invasive treatments foraortic disorders.
Type
B2c
Founded
1999
Raised
$185M
Follow us
Alexa global traffic share
Latest funding
$170,000,000
Post-IPO debt - 2017
$15,000,000
Venture capital - 2010
Essex Woodlands Health Ventures
Team Size
500+
Employees
$170,000,000 Post-IPO debt
socalTECH.com

Endologix Gets $170M Credit Facility